Browse by Section 100 Item List

HIGHLY SPECIALISED DRUGS PROGRAM (Public Hospital)

For Highly Specialised Drugs prescribed through public hospitals, claiming and approval of authority prescriptions is administered by Services Australia. Maximum quantities and repeats for Highly Specialised Drugs are listed in the Schedule. Highly Specialised Drugs prescribed through public hospitals, except Complex Authority Required Highly Specialised Drugs, are Authority required (STREAMLINED) PBS Prescriptions. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats. Complex Authority Required Highly Specialised Drugs require written authority applications. Approval of authority prescriptions by Services Australia may be obtained either by posting an Authority Prescription Form to Services Australia, or by using the Services Australia Authority free-call service (1800 888 333). Prescribers must quote the provider number of the hospital when applying.

Public hospital prescriptions for Highly Specialised Drugs can be dispensed by public hospital pharmacies. A patient will be required to pay a contribution for each supply of a highly specialised drug at a similar rate to the Pharmaceutical Benefits Scheme. Commonwealth subsidy is not available for hospital in-patients.

Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.

  • Legend
  • MPMedical Practitioner
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MP 5647F DARBEPOETIN ALFAdarbepoetin alfa 60 microgram/0.3 mL injection, 0.3 mL pen device 8 8 5
MP 5650J DARBEPOETIN ALFAdarbepoetin alfa 150 microgram/0.3 mL injection, 0.3 mL pen device 8 8 5
MP 5649H DARBEPOETIN ALFAdarbepoetin alfa 100 microgram/0.5 mL injection, 0.5 mL pen device 8 8 5
MP 5643B DARBEPOETIN ALFAdarbepoetin alfa 150 microgram/0.3 mL injection, 4 x 0.3 mL syringes 2 8 5
MP 5651K DARBEPOETIN ALFAdarbepoetin alfa 100 microgram/0.5 mL injection, 4 x 0.5 mL syringes 2 8 5
MP 5641X DARBEPOETIN ALFAdarbepoetin alfa 50 microgram/0.5 mL injection, 4 x 0.5 mL syringes 2 8 5
MP 5644C DARBEPOETIN ALFAdarbepoetin alfa 80 microgram/0.4 mL injection, 4 x 0.4 mL syringes 2 8 5
MP 5638R DARBEPOETIN ALFAdarbepoetin alfa 20 microgram/0.5 mL injection, 4 x 0.5 mL syringes 2 8 5
MP 5642Y DARBEPOETIN ALFAdarbepoetin alfa 60 microgram/0.3 mL injection, 4 x 0.3 mL syringes 2 8 5
MP 5639T DARBEPOETIN ALFAdarbepoetin alfa 30 microgram/0.3 mL injection, 4 x 0.3 mL syringes 2 8 5
MP 5648G DARBEPOETIN ALFAdarbepoetin alfa 80 microgram/0.4 mL injection, 0.4 mL pen device 8 8 5
MP 5646E DARBEPOETIN ALFAdarbepoetin alfa 40 microgram/0.4 mL injection, 0.4 mL pen device 8 8 5
MP 5645D DARBEPOETIN ALFAdarbepoetin alfa 20 microgram/0.5 mL injection, 0.5 mL pen device 8 8 5
MP 5640W DARBEPOETIN ALFAdarbepoetin alfa 40 microgram/0.4 mL injection, 4 x 0.4 mL syringes 2 8 5
MP 5637Q DARBEPOETIN ALFAdarbepoetin alfa 10 microgram/0.4 mL injection, 4 x 0.4 mL syringes 2 8 5
MP 11533B DEFERASIROXdeferasirox 360 mg tablet, 30 6 180 5
MP 11536E DEFERASIROXdeferasirox 360 mg tablet, 30 6 180 2
MP 11555E DEFERASIROXdeferasirox 360 mg tablet, 30 6 180 2
MP 11500G DEFERASIROXdeferasirox 180 mg tablet, 30 6 180 2
MP 11535D DEFERASIROXdeferasirox 180 mg tablet, 30 6 180 2
MP 11556F DEFERASIROXdeferasirox 180 mg tablet, 30 6 180 5
MP 11499F DEFERASIROXdeferasirox 90 mg tablet, 30 6 180 5
MP 11519G DEFERASIROXdeferasirox 90 mg tablet, 30 6 180 2
MP 11534C DEFERASIROXdeferasirox 90 mg tablet, 30 6 180 2
MP 5657R DEFERIPRONEdeferiprone 500 mg tablet, 100 3 300 5
MP 5658T DEFERIPRONEdeferiprone 100 mg/mL oral liquid, 250 mL 5 5 5
MP 11747G DEFERIPRONEdeferiprone 1 g tablet, 50 6 300 5
MP 5661Y DESFERRIOXAMINEdesferrioxamine mesilate 2 g injection, 1 vial 60 60 5
MP 5662B DESFERRIOXAMINEdesferrioxamine mesilate 500 mg injection, 10 vials 40 400 5
MP 5704F DORNASE ALFAdornase alfa 2.5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules 2 60 5
MPNP 5705G DOXORUBICIN HYDROCHLORIDE (AS PEGYLATED LIPOSOMAL)doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, 10 mL vial 4 4 5
MP 12309W DUPILUMABdupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes 1 2 8
MP 12318H DUPILUMABdupilumab 200 mg/1.14 mL injection, 2 x 1.14 mL syringes 1 2 5
MP 12293B DUPILUMABdupilumab 300 mg/2 mL injection, 2 x 2 mL syringes 1 2 8
MP 12302L DUPILUMABdupilumab 300 mg/2 mL injection, 2 x 2 mL syringes 1 2 5